Vertigenius

A joint RCSI/TCD spin-out company, Vertigenius™ has developed a digital platform to enhance and expand treatment options for patients experiencing vertigo, dizziness, and imbalance, to enable more efficient patient care and remote monitored treatment.

Vertigenius is an easy to use platform that lets the clinician design, prescribe and deploy custom exercises in an easy to use clinician portal. Patient can access to the easy-to-use smartphone app which digitally delivers, measures and tracks vestibular rehabilitation. This is combined with a breakthrough head sensor which connects easily with Bluetooth to the patient’s phone. It then tracks the head movement while exercising, leading to iterative improvements in outcomes.

Promoters

• Dr Dara Meldrum, Inventor, CSO and Founder
• Mark Barry, CEO

Current status

• Closed a seed €2.1m round led by Atlantic Bridge